75
August 15, 2024 at 11:28 PM
The U.S. Food and Drug Administration on Thursday approved AstraZeneca’s blockbuster cancer drug, Imfinzi, to treat patients with a type of small-cell lung cancer. (Reporting by Christy Santhosh; Editing by Anil D’Silva)
Access the original article.
Legal Notice
Legal Notice
Contact us for any correction requests
© Reuters – 2024